ClinVar Miner

Submissions for variant NM_000051.3(ATM):c.2192dup (p.Tyr731Ter) (rs1478081526)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000780925 SCV000918580 likely pathogenic Ataxia-telangiectasia syndrome 2018-12-14 criteria provided, single submitter clinical testing Variant summary: ATM c.2192dupA (p.Tyr731X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (eg. c.3049C>T (p.Gln1017X), c.3372C>G (p.Tyr1124X), c.3663G>A (p.Trp1221X)). The variant allele was found at a frequency of 4.1e-06 in 246020 control chromosomes (gnomAD). c.2192dupA has been reported in the literature in individuals affected with Ataxia-Telangiectasia and Breast Cancer (Nunziato_2019, Magliozzi_2006, Saviozzi_2003). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. However, a ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) exists for a different variant (ATM c.2193C>A) which causes the same protein alteration (p.Tyr731*) as the variant reported here; the specific variant is cited in ClinVar as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Invitae RCV000780925 SCV000964405 pathogenic Ataxia-telangiectasia syndrome 2018-12-26 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Tyr731*) in the ATM gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in an individual affected with ataxia telangiectasia (PMID: 12655570). Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.